BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang HY, Yao ZH, Tang H, Zhao Y, Jin SL, Zhou WP, Yao SN, Yang SJ, Liu YY, Luo SX. A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma. Oncotarget 2017;8:7540-7. [PMID: 27902478 DOI: 10.18632/oncotarget.13602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Wang Y, Jiang W, Ni R, Wang Y, Ni S. CDK14 involvement in proliferation migration and invasion of esophageal cancer. Ann Transl Med 2019;7:681. [PMID: 31930082 DOI: 10.21037/atm.2019.11.105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Zhu T, Yang Q, Shao J, Chen Z, Cai B, Mao G. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery. Virchows Arch 2021. [PMID: 34313839 DOI: 10.1007/s00428-021-03153-y] [Reference Citation Analysis]